Filing Details

Accession Number:
0001209191-23-046000
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-16 16:07:47
Reporting Period:
2023-08-14
Accepted Time:
2023-08-16 16:07:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1645460 Cue Biopharma Inc. CUE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190121 R Daniel Passeri C/O Cue Biopharma, Inc.
40 Guest Street
Boston MA 02135
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-14 3,000 $2.86 134,578 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct